Alnylam Pharmaceuticals, Inc. - Common Stock (NQ:ALNY)
280.50
-0.75
(-0.27%)
Streaming Delayed Price
Updated: 10:06 AM EDT, Jul 15, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 82,764 |
| Open | 281.70 |
| Bid (Size) | 280.05 (40) |
| Ask (Size) | 280.96 (40) |
| Prev. Close | 281.26 |
| Today's Range | 279.65 - 284.80 |
| 52wk Range | 273.11 - 495.55 |
| Shares Outstanding | 118,847,693 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Alnylam to Host Tenth “RNAi Roundtable” Webcast Series
June 12, 2026
Alnylam Issues 2025 Corporate Responsibility Report
May 19, 2026
Alnylam (ALNY) Q1 2026 Earnings Transcript ↗
April 30, 2026
Frequently Asked Questions
Is Alnylam Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Alnylam Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Alnylam Pharmaceuticals, Inc. - Common Stock trade on?
Alnylam Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Alnylam Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Alnylam Pharmaceuticals, Inc. - Common Stock is ALNY on the Nasdaq Stock Market
What is the current price of Alnylam Pharmaceuticals, Inc. - Common Stock?
The current price of Alnylam Pharmaceuticals, Inc. - Common Stock is 280.50
When was Alnylam Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Alnylam Pharmaceuticals, Inc. - Common Stock was at 07/15/26 10:06 AM ET
What is the market capitalization of Alnylam Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Alnylam Pharmaceuticals, Inc. - Common Stock is 33.34B
How many shares of Alnylam Pharmaceuticals, Inc. - Common Stock are outstanding?
Alnylam Pharmaceuticals, Inc. - Common Stock has 33B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.